טוען...
Treatment of Diabetic Kidney Disease: Current and Future
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. However, only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD. In 2019, sodium-glucose cotransporter 2 (SGLT2) inhibitor showed efficacy against DKD in Canagliflozin and Renal Even...
שמור ב:
| הוצא לאור ב: | Diabetes Metab J |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Diabetes Association
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850867/ https://ncbi.nlm.nih.gov/pubmed/33508907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2020.0217 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|